SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001213900-24-034117
Filing Date
2024-04-18
Accepted
2024-04-18 16:17:12
Documents
10

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ea0203954-s1_virpaxpharma.htm S-1 470200
2 FORM OF PLACEMENT AGENCY AGREEMENT ea020395401ex1-1_virpax.htm EX-1.1 48246
3 FORM OF COMMON WARRANT ea020395401ex4-4_virpax.htm EX-4.4 89768
4 FORM OF PRE-FUNDED WARRANT ea020395401ex4-5_virpax.htm EX-4.5 94235
5 OPINION OF BLANK ROME LLP ea020395401ex5-1_virpax.htm EX-5.1 15250
6 FORM OF SECURITIES PURCHASE AGREEMENT TO BE ENTERED INTO IN THIS OFFERING ea020395401ex10-40_virpax.htm EX-10.40 253430
7 CONSENT OF EISNERAMPER LLP ea020395401ex23-1_virpax.htm EX-23.1 2376
8 FILING FEE TABLE ea020395401ex-fee_virpax.htm EX-FILING FEES 32498
9 GRAPHIC image_001.jpg GRAPHIC 4282
10 GRAPHIC ex5-1_001.jpg GRAPHIC 5636
  Complete submission text file 0001213900-24-034117.txt   1021058
Mailing Address 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312
Business Address 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312 610-727-4597
Virpax Pharmaceuticals, Inc. (Filer) CIK: 0001708331 (see all company filings)

IRS No.: 821510982 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-278796 | Film No.: 24854505
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)